However, the variance between the two groups did not reach statistical significance.
← all excerpts
Enhanced healing of critical-sized bone defects using degradable scaffolds with tailored composition through immunomodulation and angiogenesis.
2
—
—
The sentences
The expression of the M1 marker (CD86) revealed a notable trend across the scaffold groups: HA-PELGA (18/1) scaffold exhibited a higher level of expression at week 6, which shifted to HA-PELGA (9/1) scaffold by week 18.